Direxion Daily S&P Biotech Bull 3X ETF
LABU
16 hedge funds and large institutions have $12.2M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
23% more funds holding
Funds holding: 13 → 16 (+3)
0.01% more ownership
Funds ownership: 0.21% → 0.22% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
5% less capital invested
Capital invested by funds: $12.9M → $12.2M (-$679K)
58% less call options, than puts
Call options by funds: $10M | Put options by funds: $23.7M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$5.1M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.23M |
| 3 |
Jane Street
New York
|
+$887K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$408K |
| 5 |
CT
CMT Trading
Chicago,
Illinois
|
+$327K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
-$3.25M |
| 2 |
CG
Cutler Group
San Francisco,
California
|
-$1.27M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$788K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$585K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
-$249K |
LABU Hedge Fund Activity: Q1 2017 in Review
16 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2017, worth a combined $12.2M — down 5.3% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LABU positions and 6 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $5.1M. The largest seller was Traynor Capital Management, cutting an estimated $3.25M.
- 16 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2017, up from 13 in Q4 2016.
- Funds reported $12.2M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2017, down 5.3% quarter-over-quarter.
- 10 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2017 and 6 closed out, a net change of +4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2017 was Virtu Financial, an estimated $5.1M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2017 was Traynor Capital Management, an estimated $3.25M sold.
Based on aggregated 13F filings for Q1 2017.